Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Total Liabilities (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Total Liabilities data on record, last reported at $116.2 million in Q3 2025.

  • For Q3 2025, Total Liabilities fell 16.88% year-over-year to $116.2 million; the TTM value through Sep 2025 reached $116.2 million, down 16.88%, while the annual FY2024 figure was $145.9 million, 12.1% down from the prior year.
  • Total Liabilities reached $116.2 million in Q3 2025 per FBIO's latest filing, down from $122.5 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $244.3 million in Q4 2022 and bottomed at $116.2 million in Q3 2025.
  • Average Total Liabilities over 5 years is $176.3 million, with a median of $168.6 million recorded in 2024.
  • Peak YoY movement for Total Liabilities: soared 63.17% in 2021, then crashed 32.07% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $170.6 million in 2021, then skyrocketed by 43.16% to $244.3 million in 2022, then crashed by 32.07% to $165.9 million in 2023, then dropped by 12.1% to $145.9 million in 2024, then dropped by 20.32% to $116.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $116.2 million in Q3 2025, $122.5 million in Q2 2025, and $145.6 million in Q1 2025.